Alisertib in Combination With Weekly Paclitaxel in Patients With Advanced Breast Cancer or Recurrent Ovarian Cancer-Reference-Cited by-同舟云学术

Alisertib in Combination With Weekly Paclitaxel in Patients With Advanced Breast Cancer or Recurrent Ovarian Cancer

Published:2019-01-10 Issue:1 Volume:5 Page:e183773
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Falchook Gerald¹,Coleman Robert L.²,Roszak Andrzej³,Behbakht Kian⁴,Matulonis Ursula⁵,Ray-Coquard Isabelle⁶,Sawrycki Piotr⁷,Duska Linda R.⁸,Tew William⁹,Ghamande Sharad¹⁰,Lesoin Anne¹¹,Schwartz Peter E.¹²,Buscema Joseph¹³,Fabbro Michel¹⁴,Lortholary Alain¹⁵,Goff Barbara¹⁶,Kurzrock Razelle¹⁷,Martin Lainie P.¹⁸,Gray Heidi J.¹⁶,Fu Siqing²,Sheldon-Waniga Emily¹⁹,Lin Huamao Mark¹⁹,Venkatakrishnan Karthik¹⁹,Zhou Xiaofei¹⁹,Leonard E. Jane¹⁹,Schilder Russell J.²⁰

Affiliation:

1. Sarah Cannon Research Institute at HealthONE, Denver, Colorado

2. University of Texas, MD Anderson Cancer Center, Houston

3. Greater Poland Cancer Centre/University of Medical Sciences, Poznan, Poland

4. Department of Gynecologic Oncology, University of Colorado School of Medicine, Aurora

5. Gynecologic Oncology Program, Dana-Farber Cancer Institute, Boston, Massachusetts

6. Centre Léon Bérard & University Claude Bernard, Lyon, France

7. Department of Oncology and Chemotherapy, L. Rydygiera District Hospital, Torun, Poland

8. University of Virginia Health System, Charlottesville

9. Memorial Sloan Kettering Cancer Center, New York, New York

10. Georgia Cancer Center at Augusta University, Augusta, Georgia

11. Centre Oscar Lambret, Lille, France

12. Yale University School of Medicine, New Haven, Connecticut

13. Arizona Oncology Associates PC, Tucson, Arizona

14. Institut Regional du Cancer, Montpellier, France

15. Centre Catherine de Sienne, Nantes, France

16. University of Washington, Seattle

17. San Diego Moores Cancer Center, La Jolla, California

18. Fox Chase Cancer Center, Philadelphia, Pennsylvania

19. Millennium Pharmaceuticals Inc (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited), Cambridge, Massachusetts

20. Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Reference37 articles.

1. Aurora kinases.;Bolanos-Garcia;Int J Biochem Cell Biol,2005

2. Aurora A kinase (AURKA) in normal and pathological cell division.;Nikonova;Cell Mol Life Sci,2013

3. Loss of aurora A/STK15/BTAK overexpression correlates with transition of in situ to invasive ductal carcinoma of the breast.;Hoque;Cancer Epidemiol Biomarkers Prev,2003

4. Targeting aurora kinase with MK-0457 inhibits ovarian cancer growth.;Lin;Clin Cancer Res,2008

5. Expression of Aurora A (but not Aurora B) is predictive of survival in breast cancer.;Nadler;Clin Cancer Res,2008

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AURKA Activates FOXO3a to Form a Positive Feedback Loop in the Proliferation and Migration of Keloid Fibroblasts;Advances in Wound Care;2024-08-12

2. Aurora Kinase A Inhibition Potentiates Platinum and Radiation Cytotoxicity in Non-Small-Cell Lung Cancer Cells and Induces Expression of Alternative Immune Checkpoints;Cancers;2024-08-09

3. Mitotic kinases are emerging therapeutic targets against metastatic breast cancer;Cell Division;2024-06-17

4. Cell cycle machinery in oncology: A comprehensive review of therapeutic targets;The FASEB Journal;2024-06-07

5. Unveiling the potential of estrogen: Exploring its role in neuropsychiatric disorders and exercise intervention;Pharmacological Research;2024-06